Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Emodin¿¡ ÀÇÇÑ Myeloid Cell Leukemia-1 ´Ü¹éÁú ¾ïÁ¦¸¦ ÅëÇÑ Á¡¾×Ç¥ÇǾç¾ÏÁ¾¼¼Æ÷ÁÖ¿¡¼­ÀÇ apoptosis À¯µµ ±âÀü

Apoptotic Effect of Emodin through Down-Regulation of Myeloid Cell Leukemia-1 in Mucoepidermoid Carcinoma Cells

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2011³â 35±Ç 1È£ p.1 ~ 6
ÃÖ°æÈñ, Á¶³²Ç¥, Á¶¼º´ë,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ°æÈñ ( Choi Kyeong-Hee ) - ÀüºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­º´¸®Çб³½Ç
Á¶³²Ç¥ ( Cho Nam-Pyo ) - ÀüºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­º´¸®Çб³½Ç
Á¶¼º´ë ( Cho Sung-Dae ) - ÀüºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­º´¸®Çб³½Ç

Abstract


Emodin is a bioactive compound isolated from the root and rhizomes of Rheum plamatum L. (polygenaceae), which is known as a traditional Chinese and Japanese medicine. In the present study, the effect of emodin on YD-15 mucoepidermoid carcinoma cells and its molecular mechanism were investigated. This study shows that emodin significantly inhibits the growth of YD-15 cells. Activation of caspase-3 and PARP is triggered by emodin and it increases sub-G1 population and the number of YD-15 cells with nuclear condensation and fragmentation. In addition, we found that emodin significantly decreases myeloid cell leukemia 1(MCL-1). These results suggest that MCl-1 is an important molecule for emodin-induced apoptosis. Taken together, emodin inhibits cell viability and induces apoptosis via down-regulation of MCL-1 and it can be a new potent anticancer drug candidate for the treatment of mucoepidermoid carcinoma.

Å°¿öµå

Mucoepidermoid carcinoma cells; Emodin; Apoptosis; Myeloid cell leukemia 1

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI